RMD Open Podcast

All Episodes (17)

From new to old

From new to old From old to new

1. 

   1. Promoting gender equity in academic rheumatology

   In this podcast, Dr. Javier Rodríguez-Carrio talks to Dr. Pavel Ovseiko and Prof. Laura Coates about the recent paper on gender equity in academic rheumatology which emerged from a EULAR task force. They discuss the current situation of gender equity in academic rheumatology across Europe, the pros and cons of potential interventions to accelerate gender-equitable career advancement in this field and how and these be applied in the short- and long-term. Link to the viewpoint: https://rmdopen.bmj

   Feb 21,2023 29:04
2. 

   2. Autoantibodies against PTM proteins as biomarkers for lupus

   Autoantibodies against post-translationally modified proteins (PTM) are described in various rheumatic diseases and facilitate diagnosis and patient stratification. Researchers from the Leiden University Medical Center analysed the presence of autoantibodies against six different post-translational modifications in a cohort of patients with neuropsychiatric lupus. In this podcast, Leendert Trouw, Rory Monahan and Michelle van den Beukel discuss the results of their study with the ARD/RMDopen soc

   Jan 13,2023 09:46
3. 

   3. Balancing risks with JAK inhibitors in RMDs after the ORAL Surveillance study

   In this podcast, Dr. Javier Rodríguez-Carrio (1) talks to Dr. Tue Kragstrup (2) about the recent safety data on JAK inhibitors emerged after the ORAL Surveillance study. They discuss what is the current situation, the potential strategies to escape a ‘static’ situation, by managing uncertainty in the context of balancing risks, patient preferences and shared-decision process.Read the Open Access related paper: https://rmdopen.bmj.com/content/8/1/e002236(1) Javier Rodríguez-Carrio (University of

   Jul 15,2022 17:10
4. 

   4. Air pollution associated with higher risk of developing autoimmune diseases

   In this podcast, RMD Open's Social Media Advisor, Dr. Paul Studenic, speaks to Dr. Giovanni Adami, from Universita degli Studi di Verona, Italy, about his population-based cohort study evaluating air pollution-associated risk of developing an immune-mediated disease. By using an Italian-wide patient-dataset, initially designed for fracture risk assessment in women in combination with data for air-quality control stations across Italy, he presents results indicating that long-term exposure to air

   Jun 01,2022 18:44
5. 

   5. COVID-19 and cytokines - same storm, different origins?

   In this podcast, Caroline Ospelt (Department of Rheumatology, University Hospital of Zurich, Switzerland) talks to Alessia Alunno (Rheumatology Unit, University of Perugia, Italy) about the similarities and differences in the cytokine storm that occurs in COVID-19 patients and people with rheumatic diseases.Link to related paper: https://rmdopen.bmj.com/content/6/1/e001295

   Jun 10,2020 11:02
6. 

   6. Imaging in large vessel vasculitis

   A systematic literature review on imaging techniques for diagnosis, outcome prediction and disease monitoring in large vessel vasculitis informing the European League Against Rheumatism recommendations is discussed in this podcast by two of the authors of the paper: Dr. Christina Duftner, rheumatologist at the Medical University Innsbruck, Austria, and Dr. Sofia Ramiro, rheumatologist at Leiden University Medical Center, The Netherlands.Read the paper on the RMD Open website: https://rmdopen.bmj

   Nov 09,2018 09:15
7. 

   7. The use of MRI in rheumatology

   RMD Open Editor-in-Chief Professor Bernard Combe talks to Professor Annette van der Helm from Leiden University Medical Center about the use of MR imaging in the diagnosis and classification of rheumatic and musculoskeletal diseases. Professor van der Helm briefly summarises the pros and cons of MR imaging in comparison with the use of CT images, and highlights some of the technical challenges of this technique. For further information on this topic please read this viewpoint article published i

   Sep 18,2018 03:25
8. 

   8. Improving the peer review skills of young researchers in rheumatology

   What is peer-review and why is important? EMEUNET, the Emerging EULAR (European League Against Rheumatism) Network, organises a training program in collaboration with the EULAR journals to improve peer review skills of young researchers. Want to know more? Listen to the conversation between Dr Aurélie Najm (Nantes University Hospital, France) and Dr Javier Rodriìguez-Carrio (Universidad de Oviedo, Spain), first author of “Improving the peer review skills of young rheumatologists and researchers

   Aug 10,2018 11:02
9. 

   9. Don’t neglect nutrition in rheumatoid arthritis!

   What mistakes should be avoided in our diet? And what potentially beneficial foods should we be taking?The answers are given by Professor Maurizio Cutolo (Postgraduate School of Rheumatology, University of Genova, Genova, Italy)in this short conversation with Claire Daien (Rheumatology department, Montpellier University, France) recorded at the XVII Mediterranean Congress of Rheumatology, in Genova, Italy, in April 2018.Read the full editorial on the RMD Open website: http://rmdopen.bmj.com/cont

   Jun 13,2018 06:36
10. 

    10. A standardised catalogue of patient scenarios to improve the ranking of RA disease activity?

    To better standardise the evaluation of disease activity of rheumatoid arthritis patients, especially in moderate disease, consensus scores of their medical doctor (MD) global ratings (EGA) are needed.Dr Janet Pope (Western University of Canada) suggests the development of a catalogue of patient scenarios to decrease the wide variability of ranking among rheumatologists. She explains how that could work in this conversation with Dr Paul Studenic (Medical University Vienna, Austria).Read the stud

    May 18,2018 18:44
11. 

    11. Osteoarthritis or rheumatoid? The MDHAQ patient questionnaire role in routine rheumatology care

    Editor-in-Chief of RMD Open Bernard Combe is joined by Theodore Pincus, Rheumatologist at the Rush University, Chicago, to discuss how new screening tools such as the MDHAQ (Multidimensional Health Assessment Questionnaire) are improving diagnosis in rheumatology.To read more about these topics, visit the RMD Open website:MDHAQ/RAPID3 scores in patients with osteoarthritis are similar to or higher than in patients with rheumatoid arthritis: a cross-sectional study from current routine rheumatolo

    Mar 13,2018 06:08
12. 

    12. Sjögren’s syndrome: what do we know so far?

    Professor Xavier Mariette (Head of Rheumatology at Université Paris-Sud, France) is an expert in Sjögren's syndrome. He tells Editor-in-Chief of RMD Open Bernard Combe what is known so far about a relatively unstudied autoimmune disease characterised by dryness of the mouth and eyes which is closely linked to rheumatoid arthritis and lupus.Read more about this subject on the RMD Open website:•“Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort”

    Jan 25,2018 05:14
13. 

    13. Rheumatic immune-related adverse events of checkpoint therapy for cancer

    Cassandra Calabrese (Cleveland Clinic Foundation, Ohio, USA) speaks with Editor-in-Chief of RMD Open Bernard Combe about checkpoint inhibitors.For more information, please visit the RMD Open website, where the related article to this podcast can also be found: Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entity: http://rmdopen.bmj.com/content/3/1/e000412.

    Dec 06,2017 05:56
14. 

    14. Branded drug or biosimilar? Reasons to adopt generics in rheumatology, by Professor Jonathan Kay

    Professor Jonathan Kay (Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School and UMass Memorial Medical Center, Worcester, Massachusetts, USA) tells Editor-in-Chief of RMD Open Bernard Combe why he supports the switch from branded drugs to their cheaper biosimilar.They spoke at the EULAR conference 2017, held in Madrid, in June.For more information on this topic read:• Key design considerations on comparative clinical efficacy studies for biosimilars: adal

    Nov 06,2017 05:17
15. 

    15. Early diagnosis and treatment: the Rheumatic Diseases Portuguese Register

    Dr Joao Fonseca, head of the Rheumatology Department at the Lisbon Academic Medical Centre (Faculdade de Medicina da Universidade de Lisboa), tells Editor in Chief of RMD Open Bernard Combe how the data from the reuma.pt database is improving the early diagnosis and treatment of arthritis in Portugal.The Rheumatic Diseases Portuguese Register (Reuma.pt) was started by the Portuguese Society of Rheumatology in 2008 with the aim to register patients suffering from all the different inflammatory j

    Jul 17,2017 05:39
16. 

    16. Interleukin-17: a role in inflammatory arthritis and implication for clinical practice

    Interleukin-17 (IL-17A) is a cytokine critical for the acute defence against extracellular bacterial and fungal infections. Excess production during chronic inflammation has been associated with many inflammatory and autoimmune disorders. In this podcast, the Editor-in-Chief of RMD Open Bernard Combe and Pierre Miossec (Department of Immunology and Rheumatology, University of Lyon, France) discuss a review paper about an update on IL-17A.The review concludes that the use of IL-17 inhibition in p

    May 05,2017 13:34
17. 

    17. Welcome to RMD Open

    BMJ and EULAR are launching a new rheumatic and musculoskeletal diseases journal, RMD Open, and Editor-in-Chief Bernard Combe explains what readers and authors can look forward to.http://rmdopen.bmj.com/

    Feb 04,2015 05:39